Mark G. Slomiany
- Molecular Biology top 10%
- Oncology top 10%
- Cell Biology top 5%
- Cancer Research top 10%
- Immunology
- Co-authors
- Bryan P. TooleSteven A RosenzweigG. Daniel GrassBernard L. MariaLauren B. TolliverLu DaiChris ParsonsYang Xiao
- Topics
- Cancer, Hypoxia, and Metabolism (8 papers)Proteoglycans and glycosaminoglycans research (6 papers)Growth Hormone and Insulin-like Growth Factors (5 papers)
- Cited by
- Cell BiologyCancer ResearchOncology
- Partner nations
- United StatesIndiaChina
In The Last Decade
Mark G. Slomiany
18 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 780
- Oncology 364
- Cell Biology 344
- Cancer Research 251
- Immunology 152
Countries citing papers authored by Mark G. Slomiany
This map shows the geographic impact of Mark G. Slomiany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Slomiany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Slomiany more than expected).
Fields of papers citing papers by Mark G. Slomiany
This network shows the impact of papers produced by Mark G. Slomiany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Slomiany. The network helps show where Mark G. Slomiany may publish in the future.
Co-authorship network of co-authors of Mark G. Slomiany
This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Slomiany. A scholar is included among the top collaborators of Mark G. Slomiany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Slomiany. Mark G. Slomiany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 9 | |
| 3 | 31 | |
| 4 | 51 | |
| 5 | 43 | |
| 6 | 59 | |
| 7 | 12 | |
| 8 | 121 | |
| 9 | 100 | |
| 10 | 87 | |
| 11 | 155 | |
| 12 | 181 | |
| 13 | 10 | |
| 14 | 60 | |
| 15 | 46 | |
| 16 | 41 | |
| 17 | 88 | |
| 18 | 62 |
About Mark G. Slomiany
Mark G. Slomiany is a scholar working on Cancer Research, Cell Biology and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). The work is most often cited by research in Cell Biology (344 citations), Cancer Research (251 citations) and Oncology (364 citations). Mark G. Slomiany has collaborated with scholars based in United States, India and China. Frequent co-authors include Bryan P. Toole, Steven A Rosenzweig, G. Daniel Grass, Bernard L. Maria, Lauren B. Tolliver, Lu Dai, Lu Dai, Chris Parsons, Yang Xiao and Craig Beeson. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.